Skip to content

Other

Oxedrine [BAN]

CAS 94-07-5
35

Safety score · 0–100

Caution

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

Oxedrine [ban] is a cosmetic ingredient used in product formulations. Exercise caution due to limited available safety data.

Oxedrine is an alternate naming reference for synephrine (para-synephrine) with the same CAS number (94-07-5). The safety assessment, concerns, and EU regulatory status are identical to synephrine as described above. Cardiovascular caution is advised when used in cosmetic formulations at elevated concentrations.

Skin benefits

  • Vasoconstrictive effects may temporarily firm skin appearance
  • Used in anti-cellulite and slimming formulations

Known concerns

  • Cardiovascular effects (vasoconstriction, blood pressure elevation)
  • Interaction with caffeine and cardiovascular medications
  • Regulatory scrutiny similar to ephedrine-class compounds

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related others

35
1,3-Benzenediamine, 4-methyl-, hydrochloride (1:1)
Other
 35
1,5-Di-(beta-hydroxyethylamino)-2-nitro-4-chlorobenzene (see note 17)
Other
 35
2,2'-Methylenebis(6-bromo-4-chlorophenol)
Other
 35
2,4-DIAMINO-5-METHYLPHENETOLE HCL
Other
 35
2-CHLORO-6-ETHYLAMINO-4-NITROPHENOL
Other
 35
2-Ethylhexyl 4-(dimethylamino)benzoate / Padimate O (USAN:BAN)
Other
 35
3-(p-Chlorophenoxy)-propane-1,2-diol
Other
 35
3-Hydroxy-N-(o-tolyl)-4-[(2,4,5-trichlorophenyl)azo]naphthalene-2-carboxamide
Other

Check your shelf

Find Oxedrine [BAN] in your products.

Scan any cosmetic product with LuxSense to see if it contains Oxedrine [BAN] and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.